Company / Interest Expense per Share
AYTU BIOPHARMA, INC Interest Expense per Share History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.03
FY2022
5-year range
$0.03 / $0.03
FY2018-FY2022
Trend
-
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $18.17 to $0.03 over the past 4 years.
Based on SEC 10-K filings.
0.03 in FY2022 with a 5-year CAGR of -70.0%.
Improved from $18.17 to $0.03 over the past 4 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -70.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak interest expense per share was recorded in FY2018.
- Lowest interest expense per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0.03 | - |
| FY2021 | - | - |
| FY2020 | $0.15 | -99.2% |
| FY2018 | $18.17 | +34.1% |
| FY2017 | $13.55 | +193.1% |
| FY2016 | $4.62 | +31653.5% |
| FY2015 | $0.01 | +180.5% |
As of FY2022 · SEC Form 10-K · Last checked Jun 21, 2026